Fetma göder läkemedelsbolagen
from Börslunch Hosted by EFN Ekonomikanalen
Börslunch tar sig i detta avsnitt an läkemedelssektorn. Tillsammans med gästerna Ellinor Hult, Health Invest och Johan Unnerus, Redeye analyseras Novo Nordisk, Bioarctic, Xvivo Perfusion, Calliditas, Camurus och Fusion Pharmaceuticals.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Börslunch?
This episode is 23 minutes long.
When was this Börslunch episode published?
This episode was published on March 18, 2024.
Can I download this Börslunch episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.